Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | SCN1A | P35498 | 2/20 | 0.57 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.57 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6399743 | 0.99 | ALDH1A1 (0.67) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL28029433 | 0.99 | ALDH1A1 (0.67) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL27364778 | 0.96 | TSHR (0.65) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL6399746 | 0.92 | ALDH1A1 (0.65) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL28161619 | 0.91 | TSHR (0.58) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL28754871 | 0.90 | ALDH1A1 (0.63) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL9587930 | 0.90 | ALDH1A1 (0.73) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL5893357 | 0.89 | TSHR (0.73) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL5975125 | 0.87 | ALDH1A1 (0.74) | TSHRMAPK1CYP3A4TP53ALDH1A1 | |
| SCHEMBL5975366 | 0.87 | ALDH1A1 (0.74) | TSHRMAPK1CYP3A4TP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100041860-A1 | POLYIMIDE, DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | claimed |
| US-20100041860-A1 | POLYIMIDE, DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041860-A1 | POLYIMIDE, DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME | DDC, AOC1, DDT | TSHR 3127/4885MAPK1 1309/4885CYP3A4 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.